Real-World Effectiveness of Nirmatrelvir–Ritonavir Against Severe Outcomes of COVID-19 in Taiwan: A Nationwide Population-Based Cohort Study
-
By
-
Raymond N Kuo
-
Wanchi Chen
-
Wen-Yi Shau
-
Shan-Chwen Chang
-
September 2, 2025
-
0 min
Top Institutions in Infectious Disease
Brief introduction explaining scope and methodology.
-
#1
National Taiwan University Hospital
Taipei, Taiwan
Key Differentiators
- Infectious Diseases
- Epidemiology
- Clinical Pharmacology
-
#2
Johns Hopkins University School of Medicine
Baltimore, MD
Key Differentiators
- Infectious Diseases
- Epidemiology
- Pharmacology
-
#3
Massachusetts General Hospital / Harvard Medical School
Boston, MA
Key Differentiators
- Infectious Diseases
- Clinical Trials
- Pharmacology
-
#4
University of Oxford
Oxford, United Kingdom
Key Differentiators
- Infectious Diseases
- Epidemiology
- Pharmacology
-
#5
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
Key Differentiators
- Public Health
- Epidemiology
- Infectious Diseases
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.